Chester County News and Community Website
KING OF PRUSSIA, PA — The U.S. Food and Drug Administration (FDA) has approved ANDEMBRY® (garadacimab-gxii), developed by CSL, as the first treatment targeting factor XIIa for the prevention of …
FDA Approves ANDEMBRY® for Preventing Hereditary Angioedema Attacks Read More KING OF PRUSSIA, PA — CSL (ASX: CSL; USOTC: CSLLY) has unveiled four-year results from its pivotal HOPE-B study, demonstrating the long-term durability and safety of HEMGENIX® (etranacogene dezaparvovec-drlb), the …
CSL Reports Promising Four-Year Data on Gene Therapy for Hemophilia B Read More KING OF PRUSSIA, PA and SAN DIEGO, CA — CSL and Arcturus Therapeutics have announced that Japan’s Ministry of Health, Labor and Welfare has granted approval for their updated self-amplifying mRNA …
Japan Approves CSL and Arcturus Therapeutics’ Novel COVID-19 Vaccine KOSTAIVE Read More KING OF PRUSSIA, PA — Japan’s Ministry of Health, Labor and Welfare recently granted approval for CSL and Arcturus Therapeutics’ self-amplifying mRNA (sa-mRNA) COVID-19 vaccine, KOSTAIVE®. This updated vaccine is …
Japan Approves CSL and Arcturus’s sa-mRNA COVID-19 Vaccine, KOSTAIVE Read More KING OF PRUSSIA, PA — Biotechnology giants CSL and Arcturus Therapeutics have announced promising results from a comprehensive study of their novel COVID-19 vaccine, ARCT-154. The findings, published in Nature …
CSL and Arcturus Announce Breakthrough COVID-19 Vaccine Study Results Read More